Mass. pharma company will pay $20.75M to settle FCA lawsuit
By 
Aaron Nicodemus2020-08-25T16:50:00
A Massachusetts-based pharmaceutical company will pay $20.75 million settle a whistleblower’s allegations that the company knowingly promoted misleading instructions for a skin lesion drug that caused doctors to submit false claims to Medicare.
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
ArticleRare OIG Special Fraud Alert cautions the use of speaker programs
In a rare move, the U.S. Department of Health and Human Services’ Office of Inspector General issued a Special Fraud Alert warning of inherent fraud and abuse risks associated with speaker programs.
-
ArticleSEC enforcement priorities revert back to basics
Recent pronouncements made by the U.S. Securities and Exchange Commission leadership, alongside the recent overhaul of the SEC Enforcement Manual, collectively signal a back-to-basics enforcement approach that appears beneficial for companies in their dealings with the agency.
-
ArticleNew DOJ policy places corporate enforcement emphasis on individual misconduct
The Department of Justice (DOJ) criminal division has announced a blanket policy against prosecuting companies that voluntarily disclose criminal wrongdoing and take other steps—and holding any individuals involved accountable for their criminal activities.
More from Regulatory Enforcement
-
ArticleFCA drive to reduce its investigation costs likely to add to compliance burden for smaller firms, warn experts
The U.K. financial regulator’s move towards “impactful deterrence” could see smaller and mid-size firms come increasingly under the spotlight as the watchdog aims to tackle market-wide concerns instead of primarily focusing on large players capable of doing the most harm.
-
ArticleInternational agents take down major site where criminals traded stolen corporate info
A major online site used by cybercriminals to buy and sell information stolen from corporations and individuals worldwide has been shut down by an international enforcement action, the Department of Justice announced.
-
ArticleLuxury brands told to tighten AML compliance as Dutch regulator fines Louis Vuitton
Money laundering is no longer a concern just for financial services and real estate. It is everybody’s business. But are most businesses adequately prepared for tighter AML rules? What does compliance need to know?